会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • METHODS OF TREATMENT USING THYMUS-DERIVED COMPOSITIONS
    • 使用THYMUS衍生的组合物治疗方法
    • US20120164076A1
    • 2012-06-28
    • US13387674
    • 2010-07-02
    • Richard N. Ushijima
    • Richard N. Ushijima
    • A61K36/78A61K35/26A61K39/02A61K49/00A61K38/19A61K31/765A61P35/00A61P1/08A61K39/085
    • A61K35/26A61K36/78G01N33/0098G01N2500/00
    • Embodiments of the present invention provide processes for preparing thymus extracts and plant or fungal extracts, and more particularly provide compositions (Thyex-1-6A and -6B) produced in accordance with said processes, and methods for treatment of various conditions comprising administration of said compositions including but not limited to cancer. In preferred synergistic aspects, the inventive compositions (Thyex-1-6A and -6B) are administered in combination with a macrophage stimulating agent (e.g., beta glucan) for cancer treatment. Certain aspects relate to treating cancer, comprising: administering of a therapeutically effective amount of a thymus extract composition (Thyex-1-6A and -6B) in combination with administration of an extract of Houttuynia cordata. Further aspects comprise administration to a mammalian subject in need thereof a therapeutically effective amount of an extract of Houttuynia cordata, wherein treating or alleviating nausea is afforded. Combination or adjunctive therapies (e.g, with chemotherapeutic agents and treatments, antibody therapies, etc.) are also encompassed.
    • 本发明的实施方案提供了制备胸腺提取物和植物或真菌提取物的方法,更具体地提供了根据所述方法制备的组合物(Thyex-1-6A和-6B),以及用于治疗各种病症的方法,包括施用所述 包括但不限于癌症的组合物。 在优选的协同方面,本发明的组合物(Thyex-1-6A和-6B)与巨噬细胞刺激剂(例如,β葡聚糖)组合施用于癌症治疗。 某些方面涉及治疗癌症,其包括:施用治疗有效量的胸腺提取物组合物(Thyex-1-6A和-6B)与施用鱼腥草提取物的组合。 其它方面包括向有需要的哺乳动物受试者施用治疗有效量的鱼腥草提取物,其中提供治疗或缓解恶心。 还包括组合或辅助治疗(例如,与化学治疗剂和治疗,抗体疗法等)。
    • 10. 发明申请
    • Standardization of Botanical Products Utilizing Biological Activity as a Marker
    • 以生物活性为标记的植物产品标准化
    • US20110287115A1
    • 2011-11-24
    • US13166598
    • 2011-06-22
    • Randy Beavers
    • Randy Beavers
    • A61K36/71A61P43/00A61K36/78A61K36/718A61K36/29
    • A61K36/29A61K36/71A61K36/718
    • The present invention relates generally to herbal materials and methods for making such materials in medicinally useful and pharmaceutically acceptable forms. Particularly, the present invention relates generally to Hydrstatis canadensis (goldenseal) materials and methods for making such materials in medicinally useful and pharmaceutically acceptable forms. More particularly, the present invention relates a process which allows the standardization of the product to specified levels of bioactivity in both hydro-alcoholic tinctures and solid extracts in the processing of goldenseal materials to produce extracts which qualify as pharmaceutical grade compositions which are suitable for use in clinical or veterinary settings to treat and/or ameliorate diseases, disorders or conditions.
    • 本发明一般涉及草药材料及其制备方法,用于药用和药学上可接受的形式。 特别地,本发明一般涉及加拿大的Hydrstatis canadensis(goldenseal)材料以及用于制造这些材料的医药上可用和药学上可接受的形式的方法。 更具体地说,本发明涉及一种方法,其允许将产品标准化到含水物质加工中的两种水性醇酊剂和固体提取物中的生物活性水平以产生符合作为适合使用的药物级组合物的提取物 在临床或兽医环境中治疗和/或改善疾病,病症或病症。